OKUR (OnKure Therapeutics) Research & Development: $46.96 Mil (TTM As of Mar. 2026)


OKUR OnKure Therapeutics Inc OKUR
14 GF Score
Price $4.20
! 1 Warning Sign
View Full Analysis

What is OnKure Therapeutics Research & Development?

OnKure Therapeutics OKUR -2.76% 14 Research & Development is $46.96 Mil as of Mar. 2026. GuruFocus rates OKUR with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. OnKure Therapeutics's Research & Development for the three months ended in Mar. 2026 was $11.71 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $46.96 Mil.

OnKure Therapeutics  (NAS:OKUR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

OnKure Therapeutics Research & Development Related Terms

OnKure Therapeutics Research & Development Historical Data

* Premium members only.

The historical data trend for OnKure Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OnKure Therapeutics Research & Development Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
25.86 32.12 43.80 48.26

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.01 12.61 11.92 10.72 11.71
OKUR
14GF Score
OnKure Therapeutics Inc OKUR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OnKure Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $46.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $46.96 Mil mean?
OnKure Therapeutics (OKUR) has a Research & Development of $46.96 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on OnKure Therapeutics and its competitors.
Is OnKure Therapeutics' Research & Development too high?
OnKure Therapeutics' current Research & Development is $46.96 Mil. Overall, OnKure Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does OnKure Therapeutics' Research & Development compare to PLX and MIST?
OnKure Therapeutics' Research & Development of $46.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on OnKure Therapeutics and its competitors. OnKure Therapeutics's current Research & Development is $46.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OnKure Therapeutics stock overvalued right now?
OnKure Therapeutics (OKUR) has a current Research & Development of $46.96 Mil. The current Research & Development is $46.96 Mil. OnKure Therapeutics' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For OnKure Therapeutics (OKUR), the current Research & Development is $46.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OnKure Therapeutics Business Description

Address 6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3K?. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
14GF Score

Get the complete analysis for OKUR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.20
Price